Takeda Pharmaceutical (TAK) Revenue (2017 - 2025)
Historic Revenue for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $7.7 billion.
- Takeda Pharmaceutical's Revenue rose 1191.72% to $7.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $47.7 billion, marking a year-over-year increase of 508.81%. This contributed to the annual value of $30.1 billion for FY2025, which is 173.09% up from last year.
- Per Takeda Pharmaceutical's latest filing, its Revenue stood at $7.7 billion for Q4 2025, which was up 1191.72% from $23.9 billion recorded in Q3 2025.
- In the past 5 years, Takeda Pharmaceutical's Revenue registered a high of $23.9 billion during Q3 2025, and its lowest value of $6.9 billion during Q4 2024.
- Moreover, its 5-year median value for Revenue was $7.8 billion (2024), whereas its average is $9.3 billion.
- In the last 5 years, Takeda Pharmaceutical's Revenue tumbled by 1331.66% in 2022 and then skyrocketed by 20741.15% in 2024.
- Quarter analysis of 5 years shows Takeda Pharmaceutical's Revenue stood at $7.9 billion in 2021, then dropped by 2.11% to $7.8 billion in 2022, then fell by 8.4% to $7.1 billion in 2023, then fell by 2.7% to $6.9 billion in 2024, then grew by 11.92% to $7.7 billion in 2025.
- Its Revenue stands at $7.7 billion for Q4 2025, versus $23.9 billion for Q3 2025 and $8.1 billion for Q2 2025.